CHILDREN'S ZYRTEC HIVES RELIEF (cetirizine hydrochloride) by Dr. Reddy's Laboratories is mechanism of actions cetirizine, a human metabolite of hydroxyzine, is an antihistamine; its principal effects are mediated via selective inhibition of peripheral h 1 receptors. Approved for urticaria, seasonal allergic rhinitis. First approved in 2004.
Drug data last refreshed 23h ago · AI intelligence enriched 2w ago
Children's Zyrtec Hives Relief is an oral chewable tablet containing cetirizine hydrochloride, a selective peripheral H1-receptor antagonist antihistamine. It is indicated for urticaria and seasonal allergic rhinitis in pediatric patients. Cetirizine works by inhibiting histamine-mediated allergic responses without significant central nervous system penetration.
As LOE approaches, brand teams face portfolio pressure and declining resources; focus shifts to lifecycle extension or asset transition.
Mechanism of Actions Cetirizine, a human metabolite of hydroxyzine, is an antihistamine; its principal effects are mediated via selective inhibition of peripheral H 1 receptors. The antihistaminic activity of cetirizine has been clearly documented in a variety of animal and human models. In vivo…
Worked on CHILDREN'S ZYRTEC HIVES RELIEF at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine
Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition
Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions
Working on Children's Zyrtec Hives Relief offers limited growth opportunity given LOE approaching status and zero linked job postings; best suited for those seeking transition to generic/competitive strategy or portfolio lifecycle management experience. Career development is constrained by product maturity and competitive commoditization in the antihistamine space.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo